About Us
UV Clinical is a company specialized in the development of devices using ultraviolet light. We are headquartered in Denmark.
UV Clinical
About UV Clinical
UV Clinical has developed a platform technology for microbial reduction on the inner surfaces of medical tubes. The medical device uses UVC light transmitted and distributed through the lumen of medical tubes.
The company was founded in 2017 by Jimmy Bak as a spin-off from the Technical University of Denmark (DTU).
In the following years (2017 - 2021) the company developed and extensively tested prototypes of its solution. This was followed by a proof of concept, demonstrating a 6-log reduction of selected pathogens inside medical tubes such as endotracheal tubes and hemodialysis catheters (in vitro).
In 2021 Rolf H. Sprunk-Jansen acquired the majority of the shares and became Chief Executive Officer,
focused on developing a world-class medical device together with Jimmy. In 2023, Peter Selmer Gade came on board as Technical Product Owner.
Our Mission
To save and improve patients’ lives in the healthcare sector.
Our Vision
A future where bacteria and biofilm in medical tubing is no longer a health issue.
Management Team
Rolf H. Sprunk-Jansen
CEO & Largest Shareholder
M.Sc. Business Administration
Current Role
Rolf H. Sprunk-Jansen, M. Sc. in Business Administration, joined UV Clinical A/S in August 2021 as CEO and majority shareholder. He is responsible for the company’s overall management, strategic direction, and commercial development. Under his leadership, UV Clinical is advancing its patented medical technology platform toward regulatory approval and market launch.
Expertise
Prior to joining UV Clinical, Rolf was co-founder and CEO of a high-tech LED company. Over nine years, he led this company from inception to a successful listing on Nasdaq First North. During this period, he spearheaded multiple funding rounds, built international sales channels, established a fully automated production facility for the company’s prizewinning luminaires, and launched several spin-off ventures.
Before that, Rolf co-founded a herbal medicine company (2003). As Chief Executive Officer, he set up corporate headquarters in Denmark with an operations center in Lithuania and grew the company’s reach by establishing distributor networks in Estonia, Latvia, Sweden, and Poland. Under his direction, the company successfully introduced nine products in five countries and received Frost & Sullivan’s Entrepreneurial Company Award in 2005.
With 25 years of executive experience, Rolf is recognized as a dynamic and results-driven leader with a proven track record in raising capital, scaling high-tech businesses, driving innovation, and building high-performance teams. He has held senior leadership roles in several leading technology and industrial companies.
Jimmy Bak
CTO & Founder
Jimmy Bak, M.Sc. in Physics and Chemistry and a Master’s in Applied Statistics, serves as Chief Technology Officer and founder of UV Clinical A/S. Since launching the company in 2017, he has led its development of clinical-grade UVC-based disinfection solutions, bridging cutting-edge photonics research with real-world healthcare applications. As CTO, he is responsible for the company’s scientific direction, innovation pipeline, and intellectual property portfolio.
Expertise
With over 25 years of experience as a senior scientist at Risø National Laboratory and the Technical University of Denmark (DTU), his work has focused on advanced spectroscopy, particularly in the infrared and UV/VIS spectral ranges. His research into UVC LED technologies for medical disinfection led to the invention of a patented system specifically tailored to narrow medical tube lumens.
Jimmy has authored numerous peer-reviewed articles and holds several patents in the field of UVC photonics and disinfection. His career combines scientific depth, entrepreneurial drive, and a proven ability to translate laboratory discoveries into commercially viable health solutions.
Peter Selmer Gade
Technical Product Owner
Current Role
Peter Selmer Gade, M. Sc. in Electrical Engineering, joined UV Clinical A/S in 2023 as Technical Product Owner, where he leads the development of the company’s disinfection technology. He is responsible for driving product innovation from concept through verification and validation, with a focus on practical engineering, clinical relevance, and robust, manufacturable solutions. Peter owns his own product design company, Napkin Design, that excels at effectively developing conceptual ideas into market-ready solutions.
Expertise
Peter brings a strong interdisciplinary background in electrical engineering, spectroscopy, optics, and system design, with hands-on experience across hardware, firmware, and software integration. Prior to joining UV Clinical, he held technical leadership roles at major life science companies such as Novo Nordisk and Lundbeck, where he contributed to complex R&D projects within regulated environments. He has also founded and led engineering ventures focused on translating scientific insight into commercially viable medical technologies. With an expert knowledge of regulatory frameworks such as FDA 510(k), IEC 60601, and ISO 14971, Peter collaborates closely with quality, engineering, and human factors teams to ensure technical execution aligns with both clinical needs and product strategy. He is recognized for his data-driven approach - relying on experimental validation, clinician feedback, and iterative prototyping to deliver safe, effective, and scalable solutions.
Board of Directors
Helge Holm-Larsen
Chairman of the Board of Directors
Skilled C-level executive and board member in tech start-up companies, particularly within automation, clean tech and medical devices. Degrees in Chemical Engineering (DTU) and International Trade (CBS). Selected key roles: CEO, SDI – SDI invests in innovative early-stage tech-based companies within Industry, Cleantech, IKT & Big Data and Medical Device. SDI holds ownership positions in 28 companies. Former Chairman of the Board, FOM Technologies. FOM specializes in machines and equipment for slot-die coating of functional materials. FOM Technologies was the most successful IPO on the Nasdaq First North in 2020. In 2021, FESE named FOM Technologies the best European IPO in the Rising Star Category. Board member, Vulcur Medtech. Vulcur Medtech is developing FlashHeal, a medical device for painless treatment for chronic wounds to help prevent amputations among diabetic patients and other chronic wound patients.
Emilio de la Guardia
Member of the Board of Directors
Double Degree in Law and History from the University of Navarra, MBA McGill University, Master in EEC Law from the College of Europe (Bruges). More than 30 years´ experience in the finance sector in corporate financing, structuring of project financing operations and venture capital; investment banking (mergers and acquisitions, LBOs and MBOs). Proven track record in finance leadership in lending, structuring, venture capital, private equity, and mergers and acquisitions for public, private and hybrid entities. Private equity investor and startup-company entrepreneur, founder, and principal. Joined the European Investment Bank (EIB) in 1987 where he has been responsible for financing operations in several different countries: Italy, France, United Kingdom, Morocco, Portugal, Spain. These included finance projects for Airbus, Euro Disney program and the Euro Tunnel. Further, in JASPERS (joint EIB/EU/EBRD Commission initiative) he was Country Manager for Hungary, Romania, Bulgaria, Cyprus, Malta, extending later as well to Poland, Czech Republic and Baltic States (Estonia, Lithuania, and Latvia). Five years in COFIDES (Bilateral Promotion Agency of Spain) as General Delegate for Morocco and North Africa, based in Casablanca. Founding partner and Director of APD Morocco. Partner and Vice President of Maderfibra Internacional (industrial wood packaging company) in Spain and Dubai. Currently member of the Board of industrial companies and investment funds in Luxembourg.
Jimmy Bak
CTO & Founder
Jimmy Bak, M.Sc. in Physics and Chemistry and a Master’s in Applied Statistics, serves as Chief Technology Officer and founder of UV Clinical A/S. Since launching the company in 2017, he has led its development of clinical-grade UVC-based disinfection solutions, bridging cutting-edge photonics research with real-world healthcare applications. As CTO, he is responsible for the company’s scientific direction, innovation pipeline, and intellectual property portfolio.
Expertise
With over 25 years of experience as a senior scientist at Risø National Laboratory and the Technical University of Denmark (DTU), his work has focused on advanced spectroscopy, particularly in the infrared and UV/VIS spectral ranges. His research into UVC LED technologies for medical disinfection led to the invention of a patented system specifically tailored to narrow medical tube lumens.
Jimmy has authored numerous peer-reviewed articles and holds several patents in the field of UVC photonics and disinfection. His career combines scientific depth, entrepreneurial drive, and a proven ability to translate laboratory discoveries into commercially viable health solutions.
Rolf H. Sprunk-Jansen
CEO & Largest Shareholder
M.Sc. Business Administration
Current Role
Rolf H. Sprunk-Jansen, M. Sc. in Business Administration, joined UV Clinical A/S in August 2021 as CEO and majority shareholder. He is responsible for the company’s overall management, strategic direction, and commercial development. Under his leadership, UV Clinical is advancing its patented medical technology platform toward regulatory approval and market launch.
Expertise
Prior to joining UV Clinical, Rolf was co-founder and CEO of a high-tech LED company. Over nine years, he led this company from inception to a successful listing on Nasdaq First North. During this period, he spearheaded multiple funding rounds, built international sales channels, established a fully automated production facility for the company’s prizewinning luminaires, and launched several spin-off ventures.
Before that, Rolf co-founded a herbal medicine company (2003). As Chief Executive Officer, he set up corporate headquarters in Denmark with an operations center in Lithuania and grew the company’s reach by establishing distributor networks in Estonia, Latvia, Sweden, and Poland. Under his direction, the company successfully introduced nine products in five countries and received Frost & Sullivan’s Entrepreneurial Company Award in 2005.
With 25 years of executive experience, Rolf is recognized as a dynamic and results-driven leader with a proven track record in raising capital, scaling high-tech businesses, driving innovation, and building high-performance teams. He has held senior leadership roles in several leading technology and industrial companies.
Advisory Board
Marie-Louise Moes Struckmann
Marie-Louise has been working with Intravascular catheter technology for over 20 years. She graduated as a doctor from the University of Copenhagen in 1992 and has undergone extensive training at hospitals in Copenhagen in surgery, particularlyvascular surgery. She obtained her PhD in 1998, an MD. in 2003 and a specialism in vascular surgery in 2008 at Rigshospitalet. She has been active in research for almost 30 years, as Research Head at Aalborg University Hospital 2009-2012 and Chief Physician of the Varicose Veins Clinic at Nyborg Hospital under Odense University Hospital 2012-2014. Since then, she has been in varicose veins clinics in Næstved, Malmø, Gothenburg and Stockholm. Marie-Louise is now running her own veins clinic in Kongens Lyngby, Denmark.
Mette Hvolbøll
Mette has extensive clinical experience. Since she graduated from Slagelse Nursing School in 1997, Mette has specialized in haemodialysis and nephrology. She has worked with numerous dialysis catheter generations in clinical settings and has seen the evolution of standards for their maintenance and hygiene. In 2017, Mette helped establish the self-service haemodialysis unit in a Danish Hospital, where she now serves as the daily manager. She is a dialysis specialist, focusing on planning, teaching, and dialysis treatment of chronic kidney patients under optimal hygienic conditions. She has worked with numerous dialysis catheter generations in clinical settings and has seen the evolution of standards for their maintenance and hygiene. In 2017, Mette helped establish the self-service haemodialysis unit in a Danish Hospital, where she now serves as the daily manager. She is a dialysis specialist, focusing on planning, teaching, and dialysis treatment of chronic kidney patients under optimal hygienic conditions.
Dr. Bhupendra Gandhi
Dr. Bhupendra Gandhi, the leading kidney doctor in India, is a highly respected nephrologist. M.B.B.S. from Grant Medical College, University of Bombay (1965), American Board of Internal Medicine (1972) and American Board in Subspecialty of Nephrology (1974). He founded the department of nephrology at Breach Candy Hospital. He is also the Honorary Nephrologist at Sir HN Reliance Foundation and Research Centre, as well as the Senior Consultant Nephrologist, Breach Candy Hospital, Mumbai since 1975. Dr. Gandhi’s extensive education and significant roles in both the United States and India reflect his dedication and expertise in nephrology. His contributions, particularly in establishing the nephrology department at Breach Candy Hospital, have had a lasting impact on the medical community.
Ganesh Malhotra
Ganesh is a seasoned professional with an MBA from XIM India and over thirty years of expertise in International Corporate Finance and Investment Banking. Founding Director of Phoenix Consultancy Enterprises Ltd / Silver Star Capital Services FZE / Impex Power FZE in Dubai. His career also includes roles at MF Global , Tata Finance, Samsung Gulf and Merrill Lynch. He has been involved in set up of a USD 400 million Real Estate Fund for India and has executed many transactions in the Real Estate , Infrastructure, Oil & Gas, Hospitality and Healthcare space. His experience includes Fund Raising and Mergers & Acquisition and Business Development. He has been based out of Dubai for over 28 years. Ganesh is also on the Board of various companies including the financial institution LKP Securities Ltd, listed on the Bombay Stock Exchange in India.
Søren Ulstrup
Søren has spent his entire career in plastic, first as an owner/CEO of the family-owned Ulstrup Plast, and later (after the merger into SP group) as an Executive Vice President at SP Group. Søren joins the UV Clinical Advisory Board to contribute his comprehensive and hands-on understanding of the injection moulding and extrusion supply chain, as well as manufacturing issues and requirements for plastic-based medical devices and the development of medical devices in general. Selected key roles: - Chairman of the Board, Plastic Industry in Denmark - Executive VP, SP Group A/S - Senior positions of trust in Danish Industry and various boards, including Coreplast and SP Group subsidiaries - Chairman of the Board in Ulstrup Invest - Investor in several early stage tech companies, including pre-IPO investor in FOM Technologies, FESE best IPO of 2020 (Rising Star) Søren has also joined UV Clinical A/S as an investor.
Gilles Trancart
Gilles Trancart has more than 35 years of experience as a top executive in the financial sector. After obtaining a PHD in Economics and Statistics from ENSAE (France), Gilles started his career at the French Central Bank as an inspectorspecialised in the supervision of market activities. As anentrepreneur, he joined ODDO BHF as general partner and contributed to the fantastic growth of the company with several M&A deals. With Credit Agricole and Lazard, he gained experience in a global role, managing teams in more than 40 countries including the US. Today, Gilles brings his leading management experience to several companies as board member or investor in startups.
Selected key roles:
- Independent board member of Inversis, bank in Madrid
- Independent board member of MCB, bank in Mauritius
- Independent board member of Antwort, P-E fund in Luxembourg
- Advisory board of Onbrane/Nasdaq
- Advisory board of Imescia (medical)
- Advisory board of CBS (French navy seals supplier)
- Advisory board of IMGA (Asset Manager in Portugal) - Senior Advisor of Accuracy (consulting)
- Senior Advisor of Accuracy (consulting)
- Senior Advisor of UV Clinical A/S Gilles is also a shareholder in UV Clinical A/S.
Peter Mørch Eriksen
Peter Mørch Eriksen has more than 20 years of experience in management and strategy work in the medical technology and life science industries. Peter, who has a master’s degree from CBS, has worked as CEO and held other senior positions within BioPorto, Sense, Medtronic, Brüel & Kjær, and with his extensive experience has driven growth and restructuring, as well as securing financing in technology-intensive international organizations. Peter Mørch Eriksen has top-level management experience in the life science industry; he has worked in major listed multinational companies as well as in startups, obtaining extensive experience in strategy work, sales, branding, marketing, finance, and management, and contributing to the development of these companies.
Peter Mørch Eriksen holds positions in the following companies:
- Chairman of the board, Fluoguide A/S (First North, Nasdaq Sweden)
- Chairman of the board, Monsenso A/S (First North, Nasdaq Denmark)
- Member of the board, Blue Vision A/S (Nasdaq Denmark)
- Member of the board, BioPorto A/S (Nasdaq Denmark)
- Chairman of the board, My Blue Label A/S (Private)
- Advisory Board, Lund University and Diabetes center (Sweden)
- Advisory Board, Medical Device & Diagnostics at Cincinnati Children’s Hospital (USA)
- Advisory Board, UV Clinical A/S
Vincent Decalf
Vincent Decalf is a seasoned independent non-executive director with over 30 years of board experience in financial services and industry. Based in Luxembourg, he serves on boards of listed and regulated entities, including a U.S. listed company, a Spanish bank, and several fund managers. A Certified Director and INSEAD IDP graduate, he is active in the Luxembourg Institute of Directors (ILA) and chairs several audit committees. Previously, Vincent held senior executive roles at Société Générale and Foyer Group, where he led major strategic integrations. He began his career at KPMG and Paribas.